Introduction: High morbidity and low mortality has been linked to bariatric surgery. The Obesity surgery mortality risk score (OS-MRS) is a validated scale for mortality risk assessment. The aim of this study was to evaluate if OS-MRS scale can also be used as a predictor of postoperative complications in obese patients submitted to primary laparoscopic gastric bypass.
Introduction
Obesity is a global health problem defined as a body mass index (BMI) greater than 30 kg/m 2 . World Health Organization states that worldwide obesity more than doubled since 1980 and in 2014 it was estimated that about 13% of the adult population were obese. In Portugal, this prevalence reached 20.1% [1] .
Bariatric Surgery experienced new developments in the last few decades, and with the advent of laparoscopy become progressively less invasive. Laparoscopic gastric bypass (LGB) is currently the most common procedure for the treatment of morbid obesity [2] . Bariatric surgery, even as an elective procedure, is associated with considerable morbidity, even though it presents low mortality (under 1.5%) [3] . Values reported for morbidity are quite discrepant varying from 3 to 20% [4] .
Recently, many scoring systems have been used to predict the mortality risk of patients proposed to bariatric surgery. Obesity surgery mortality risk score (OS-MRS) is used for patient's risk stratification and mortality risk assessment at 90 days postoperatively, and is validated by multiple centers [5] [6] [7] [8] . Simplicity is its main advantage, consisting in assigning 1 point for each of the following preoperative variables: male, age ≥ 45 years, BMI ≥ 50 kg/m 2 , and arterial hypertension (ATH), known risk factors for pulmonary thromboembolism (PTE). Patients with 0-1 points are classified as class A (low risk), with 2-3 points as class B (moderate risk) and with 4-5 points as class C (high risk). Given the low mortality described for this type of surgery, stratifying patients according to their risk of postoperative complications, rather than mortality, seems a more logical and useful approach. However, only few authors have studied the possibility of using the OS-MRS with morbidity's prediction as an end point. Sarela et al. concluded that the patients included in OSMRS class C presented more adverse events, when compared to those from classes A+B, [9] . Lorente et al [10] found complications in patients from classes B+C to be more frequent then in those from class A. However, these studies had several limitations: patients were submitted to different bariatric surgical procedures, there were multiple interventions at the same operative time, and post-operative records were analyzed only in the first 30 days.
The aim of this study was to evaluate OS-MRS as a predictor of complications at 30 and 90-days postoperative in morbidly obese patients submitted to primary laparoscopic gastric bypass.
Methods
A retrospective study was performed including all consecutive patients who underwent primary laparoscopic gastric bypass between January 1 st and December 31 st 2014, at Centro Hospitalar do Porto, Portugal.
The usual multidisciplinary preoperative evaluation (including Surgery, Endocrinology, Anesthesia, Psychiatry and Nutrition) took place in our institution, which is considered national reference for laparoscopic bariatric surgery. Patients with co-existing surgical procedures besides LGB were excluded. Most patients were admitted one day before surgery and were discharged on the 3 rd postoperative day. Anesthesia technique included induction with propofol and maintenance with desflurane to a bispectral index (BIS ® ) target of 40-60. A perfusion of remifentanil was used during the procedure. Muscle relaxation was achieved with rocuronium and reversed with sugammadex, under train-of-four neuromuscular monitoring.
Clinical electronic records were accessed to evaluate age, gender, preoperative weight, height, BMI, American Society of Anaesthesiology physical status (ASA), ATH and increased risk of PTE, defined as if there was previous history of PTE, hypoventilation (PaCO 2 >45mmHg), presence of inferior vena cava filter or a diagnosis of pulmonary hypertension.
Morbidity and mortality at 30 and 90 days following surgery were recorded. If there was not a medical appointment during this period, patients were contacted by telephone to clarify their clinical status.
Complications were classified according to Clavien-Dindo's grades [11] [12] [13] . This classification stratifies adverse events into one of 5 grades: grade I includes any deviation from normal postoperative course without the need for pharmacological or other treatment (allowing antiemetics, analgesics, diuretic, electrolytes and physiotherapy); grade II complications require blood transfusion, total parenteral nutrition or pharmacological treatment besides the one allowed on grade I; grade III requires surgical, endoscopic or radiological intervention; grade IV are life-threatening complications; and finally grade V refers to the death of a patient.
The OS-MRS was calculated, as previously described. Patients were then classified into three groups according to their score. 
Results
Eighty-five consecutive patients submitted to primary laparoscopic gastric bypass were included, of which 70 (82.4%) were female. The mean age was 44 years old (range 20-65) and the mean BMI was 44.3 ± SD 5.8 kg/m 2 . Concerning the ASA physical status, 56 patients (65.9%) were classified as ASA II, and the remaining as ASA III. The prevalence of the risk factors included in OS-MRS and their co-existence, is presented in Tables 1 and 2 .
On the OS-MRS scale, 33 patients were classified as class A (38.8%), 48 as class B (56.5%) and 4 as class C (4.7%).
No mortality cases were registered. Twenty patients (23.5%) presented at least one complication during the first 30 days. A total of 22 patients had some complication by the 90th postoperative day (25.9%) ( For statistical analysis purposes, at 90 days, this patient was considered only once, with the complication of higher grade. Of the registered complications, 5% (n=1) at 30 days, and 9% (n=2) at 90 days, were considered major, requiring surgical or endoscopic intervention.
Unimodal analysis showed statistical significance for OS-MRS scale, ASA physical status and the risk of developing PTE, regarding the occurrence of postoperative complications, both at 30 and 90 postoperative days (Table 4) .
The rate of complications in each of OS-MRS subgroups at 30 and 90 days was: 9.1% in class A (both evaluations), 31.3% and 35.4% in class B (at 30 and 90 days, respectively) and 50% in class C (both evaluations).
Due to the small sample of high-risk patients, classes B (moderate risk) and C (high risk) were grouped together for analysis. When patients classified as class A were compared to those from classes B and C, we found that the risk of general complications was significantly greater in the last group, with an odds ratio of 5. 
Discussion
In our series, there were no cases of mortality, which seems to be in line with the extremely low mortality rate described in other studies.
Although our complications' rate was higher when compared to the existing literature, only 2 major complications (2.4%) were registered, which is consistent with other studies [10, 14] . In addition, even though most complications occurred in the first 30 days, we analyzed a longer time period (90 days).
Although there are some scores designed for predicting morbidity in bariatric surgery, such as the ones developed by Gupta et al. and Turner et al., some limitations have been reported [15, 16] . Some are not exclusively designed for LGB, or are difficult to apply and their calculation is time-consuming, others are not validated in multiple centers or do not stratify patients in risk groups. OS-MRS, previously only a tool for estimating mortality, is a much simpler tool, as most of its variables are routinely gathered in a preoperative consultation. We found that OS-MRS is useful in predicting the risk of postoperative complications after laparoscopic gastric bypass, which is of great importance both for selection, patient information and decisions regarding the perioperative period and the follow-up. This seems to be in accordance with findings of both Sarela et al. and Lorente et al. [9, 10] .
In our study, when different risk factors were individually analyzed, only the risk of PTE, OS-MRS and ASA classification were related to the occurrence of complications. However, previous studies also found correlations with age, BMI, sex and ATH [16] [17] [18] [19] .
Regarding both periods analyzed (30 versus 90 days) the conclusion reached for each of them are similar; thus, although there is an advantage of predicting morbidity at 90 days, future studies for validation of this score may draw conclusions from a shorter follow-up period such as 30 days.
The OS-MRS score was useful in predicting general morbidity; the same was not valid when excluding minor complications. This, however, does not minimize its importance in the preoperative setting as a tool to stratify patients. In fact, complications of grade I, even though not demanding specific or invasive therapeutics, require postponing discharges, patients' re-admissions or additional complementary laboratorial and imagiologic exams, bringing important social and economic implications for both the patient and the institution. The study presents some limitations: small sample size, patients from only one institution, retrospective design. Even though it clearly demonstrates the ability to identify the patients with higher risk of postoperative adverse events, a larger sample might be needed to address the possibility of predicting high-grade complications. However, the prevalence of higher-grade complications in our sample seems in accordance with the literature [10, 14] . Lastly, although retrospective, the study variables included in OS-MRS are routinely assessed and registered in the clinical anesthesia pre-operative assessment of these patients.
In conclusion, there is increasing evidence that OS-MRS scale might be a useful tool to predict general morbidity after gastric laparoscopic bypass in morbidly obese patients.
This evidence allows physicians to better inform patients and decide on which strategies they could benefit for in the perioperative period.
